期刊文献+

子宫内膜样腺癌中胰岛素样生长因子及其受体基因表达模式探讨 被引量:1

Expression pattern of insulin-like growth factors and their receptors in endometrioid adenocarcinoma
原文传递
导出
摘要 目的探讨胰岛素样生长因子1(IGF-1)和IGF-2以及它们的受体、结合蛋白IGFBP-3在子宫内膜样腺癌中的表达模式,同时分析它们之间的相互关系。方法选择58例临床不同期别的子宫内膜样腺癌组织标本,同时选取癌旁组织31例、正常内膜组织42例作为对照组,采用Trizol一步法提取总RNA。TaqMan荧光实时定量聚合酶链反应(PCR)检测对照组、内膜癌组、癌旁组的IGF-1、IGF-2、IGF-1R、IGF-2R、IGFBP-3的mRNA表达,分析它们在三组中的表达差异以及相关关系。结果 IGF-1、IGF-1R、IGF-2、IGF-2R、IGFBP-3mRNA表达量在内膜癌组中分别为1.19±0.79、6.23±3.98、2.44±2.32、4.32±2.98、14.47±12.31,在癌旁组中分别为2.66±1.73、35.34±22.02、8.59±7.13、0.39±0.36、8.28±4.57,前两组均明显高于对照组中0.58±0.30、0.54±0.32、0.33±0.19、0.04±0.03、4.85±3.35,差异均有统计学意义;癌旁组与内膜癌组比较,IGF-1、IGF-1R、IGF-2的mRNA量明显升高,IGF-2R、IGFBP-3的mRNA值则下降,差异均有统计学意义。对照组中IGF-1与IGF-1R、IGF-1与IGF-2R、IGF-1与IGFBP-3、IGF-2与IGFBP-3、IGF-1R与IGFBP-3均呈中度正相关,相关系数分别为0.479、0.331、0.305、0.486、0.385,P值均<0.05,其他组合相关性没有统计学意义;内膜癌组中上述组合相关性不明显,只有IGF-1与IGF-2呈高度正相关,相关系数为0.901,P<0.05;癌旁组中,IGF-1与IGF-1R、IGF-2与IGF-1R呈高度正相关,相关系数分别为0.588、0.753,P<0.05,其他组合没有相关性。在内膜癌组中按手术病理分期、细胞分级及肌层浸润深度分组,IGF-1、IGF-2、IGF-2RmRNA表达量随着分期、分级、浸润深度的增加呈下降趋势,差异有统计学意义。结论内膜癌组织和癌旁组织中IGF-1、IGF-2、IGF-1RmRNA呈明显的高表达,以癌旁组织中更明显;IGF-1、IGF-2、IGF-1R基因高活性,可能是正常内膜向癌进展的早期高危信号。IGF-1、IGF-2、IGF-2RmRNA高表达可能提示子宫内膜样腺癌预后良好。 Objective To investigate the IGFs-mRNA expression level in endometrial adenocarcinoma and the relationship between their expression.Methods 58 specimens of endometrial adenocarcinoma and 42 normal endometrial tissue and 31 adjacent cancer lesion(paracancer) tissue were collected in Jingling hospital during Jan 2007 to Jul 2009.The total RNA was extracted using one-step Trizol method.The expressions of IGF-1,IGF-1R,IGF-2,IGF-2R,IGFBP-3 mRNA in the control group(normal endometrial tissue),endometrial carcinoma and paracancer group were detected by TaqMan fluorescent real-time quantitative PCR.The differentiation of their expression in three groups and the correlation between their expression pattern in endometrial carcinoma were analysed.Results The expression level of IGF-1,IGF-1R,IGF-2,IGF-2R,IGFBP-3 mRNA were 1.19±0.79,6.23±3.98,2.44±2.32,4.32±2.98,14.47±12.31 in cancer group,2.66±1.73,35.34±22.02,8.59±7.13,0.39±0.36,8.28±4.57 in paracancer group,and 0.58±0.30,0.54±0.32,0.33±0.19,0.04±0.03,4.85±3.35 in normal endometrium.The expression levels in endometrial cancer tissues and paracancer tissues were significantly higher than that in control group(P<0.05),while the level of IGF-1,IGF-1R,IGF-2 mRNA increased and IGF-2R,IGFBP-3 mRNA decreased in paracancer group(P<0.05) compared with endometrial cancer group.In control group,the moderately positive correlations between IGF-1 and IGF-1R,IGF-1 and IGF-2R,IGF-1 and IGFBP-3,IGF-2 and IGFBP-3,IGF-1R and IGFBP-3 were observed(rs=0.479,0.331,0.305,0.486,0.385,respectively,P<0.05).There was no statistically significant correlation between other associated pairs.Only IGF-1 was strongly positively correlated with IGF-2 in endometrial cancer group(rs=0.901,P<0.05),the correlations that showed in control were not present.The highly positive correlation between IGF-1 and IGF-1R,IGF-2 and IGF-1R were observed in paracancer tissue(rs=0.588,0.753,P <0.05).The expression of IGF-1,IGF-2,IGF-2R mRNA in endometrioid adenocarcinoma decreased with the stage,grade and depth of infiltration increased.Conclusions The activity of IGF-1,IGF-2,IGF-1R genes in paracancer tissue and in endometrial cancer tissue was markedly increased.It was a potential early high-risk signal in progression of endometrial carcinoma.The overexpression of IGF-1,IGF-2,IGF-1R mRNA might predict a good prognosis of patient with endometrioid adenocarcinoma.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第15期4356-4361,共6页 Chinese Journal of Clinicians(Electronic Edition)
基金 南京军区2008科技创新项目 江苏省第七批"六大高峰人才"(08MA092)
关键词 子宫内膜样 生长调节素类 受体 生长调节素 聚合酶链反应 Carcinoma,endometrioid Insulin-like growth factor Receptor,insulin-like growth factor Polymerase chain reaction
  • 相关文献

参考文献13

  • 1张乃怿,吴成,廖秦平.子宫内膜癌的现状和筛查[J].中华临床医师杂志(电子版),2011,5(3):124-129. 被引量:77
  • 2Eric Hébert.Mannose-6-phosphate/Insulin-like Growth Factor II Receptor Expression and Tumor Development[J]. Bioscience Reports . 2006 (1)
  • 3Werner H,Bruchim I.The insulin-like growth factor-I receptor as an oncogene. Archives of Physiology and Biochemistry . 2009
  • 4Gunter MJ,Hoover DR,Yu H,et al.A prospective evaluation of insulin-like growth factor-I as risk factor for endometrial cancer. Cancer Epidermiol Biomarkers Prev . 2008
  • 5McCampbell AS,Broaddus RR,Loose DS,et al.Overexpression of the insulin-like growth factor1recepter and activation of the AKT pathway in hyperplastic endometrium. Clinical Cancer Research . 2006
  • 6Gielen SC,Hanekamp EE,Blok LJ,et al.Steroid-modulated proliferation of human endometrial carcinoma cell lines:any role for insulin-like growth factor signaling?. Journal of the Society for Gynecologic Investigation . 2005
  • 7Hamelers,IH,Steenbergh,PH.Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocrine Related Cancer . 2003
  • 8Jasminka Pavelic,Tanja Matijevic,Jelena Knezevic.Biological&physio-logical aspects of action of insulin-like growth factor peptide family〔J〕. Indian Journal of Medical Research . 2007
  • 9McCampbell AS,Walker CL,Broaddus RR,et al.Develop-mental reprogramming of IGF signaling and susceptibility to endometrial hyperplasia in the rat. Laboratory Investigation . 2008
  • 10Kim JH,,Cho YH,Park YL,et al.Prognostic significance ofinsulin growth factor-I receptor and insulin growth factor bind-ing protein-3 expression in primary breast cancer. Oncology Reports . 2010

二级参考文献5

共引文献76

同被引文献19

  • 1Celik H, Kokcu A, Yildiz L. Endometrial sU'omal sarcoma with coexistent endometrioid adenocarcinoma in a woman with previous breast eancea:, a preliminary case report [J]. Eur J G3rnaecol Oncol, 2013, 34(5): 493-495.
  • 2Caballero Y, Tur6gano A, L6pez-Tomassetti E, et al. Endometrioid adenocarcinoma in the lower rectum [J]. Rev Esp Enferm Dig, 2013, 105(9): 567-569.
  • 3Haltia UM, BO tzow R, Leminen A, et al. FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype[J]. J Gynecol Oncol, 2014, 25(1): 30-35.
  • 4Numanoglu C, Corbacioglu Esmer A, Ulker V, et al. The prediction ofpara-aortic lymph node metastasis in endometrioid adenocarcino- ma of endometrium[J]. J Obstet Gynaecol, 2014, 34(2): 177-181.
  • 5Raghavendrachar RB, Crasta J, Siddartha PT, et al. A study of pelvic and para-aortie lymph node involvement in surgically staged endom- etrioid carcinoma of endometrium[J]. J Obstet Gynaeeol India, 2013, 63(4):240-243.
  • 6Kathuria K, Jambhekar NA, Pramesh CS, et al. A clinicopathologic analysis of 88 lung resections of suspected metastatic carcinomas with proven primaries[J]. Indian J Cancer, 2013, 50(4):356-360.
  • 7Lee TS, Jeon HW, Kim YB, et al. Aberrant MicroRNA Expression in Endometrial Carcinoma Using Formalin-Fixed Paraffin-Embedded (FFPE) Tissues[J]. PLoS One, 2013, 8(12):e81421.
  • 8王雪芹,王言奎,盛文旭,姜元庆.子宫内膜样腺癌组织HIF-1α和VEGF及ERα的表达[J].中华肿瘤防治杂志,2010,17(7):517-520. 被引量:5
  • 9任占平,石喆,张芫.子宫内膜样腺癌组织中p27、MCM7蛋白的表达及意义[J].肿瘤防治研究,2011,38(1):73-76. 被引量:16
  • 10康丽菲,李月红,张祥宏,吴文新,马毓梅,张杰英.子宫内膜样腺癌中mTOR和eIF4E蛋白表达及临床意义[J].临床与实验病理学杂志,2011,27(1):71-74. 被引量:9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部